Here is What Hedge Funds Think About UBS AG (USA) (UBS)

Judging by the fact that UBS AG (USA) (NYSE:UBS) has experienced falling interest from the entirety of the hedge funds we track, we can see that there exists a select few funds who were dropping their positions entirely heading into Q4. Interestingly, David Dreman’s Dreman Value Management said goodbye to the largest stake of all the hedgies watched by Insider Monkey, valued at about $3.6 million in stock, and Israel Englander’s Millennium Management was right behind this move, as the fund said goodbye to about $2 million worth.

Let’s go over hedge fund activity in other stocks – not necessarily in the same industry as UBS AG (USA) (NYSE:UBS) but similarly valued. We will take a look at Biogen Idec Inc. (NASDAQ:BIIB), Mondelez International Inc (NASDAQ:MDLZ), NTT Docomo Inc (ADR) (NYSE:DCM), and Westpac Banking Corporation (ADR) (NYSE:WBK). This group of stocks’ market values resemble UBS’s market value.

As you can see these stocks had an average of 35.5 hedge funds with bullish positions and the average amount invested in these stocks was $2,539 million. That figure was $793 million in UBS’s case. Mondelez International Inc (NASDAQ:MDLZ) is the most popular stock in this table. On the other hand Westpac Banking Corporation (ADR) (NYSE:WBK) is the least popular one with only 6 bullish hedge fund positions. UBS AG (USA) (NYSE:UBS) is not the least popular stock in this group but hedge fund interest is still below average. This is a slightly negative signal and we’d rather spend our time researching stocks that hedge funds are piling on. In this regard MDLZ might be a better candidate to consider a long position.